Source: GlobalNewswire

Press Release: Replay : Replay targets genetic brain disorders with new gene therapy company, Kaleibe, utilising big DNA HSV technology

Replay targets genetic brain disorders with new gene therapy company, Kaleibe, utilising big DNA HSV technology

Read full article »
Replay's Competitors | Replay's News | Replay's Financials
Stay up-to-date with the latest news on Replay
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Lachlan MacKinnon's photo - Co-Founder & CEO of Replay

Co-Founder & CEO

Lachlan MacKinnon

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Replay